CO7160021A2 - Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares - Google Patents

Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares

Info

Publication number
CO7160021A2
CO7160021A2 CO14215115A CO14215115A CO7160021A2 CO 7160021 A2 CO7160021 A2 CO 7160021A2 CO 14215115 A CO14215115 A CO 14215115A CO 14215115 A CO14215115 A CO 14215115A CO 7160021 A2 CO7160021 A2 CO 7160021A2
Authority
CO
Colombia
Prior art keywords
avian
herpes virus
vaccines
immunize
region located
Prior art date
Application number
CO14215115A
Other languages
English (en)
Inventor
Ayumi Fujisawa
Mayumi Kubomura
Sakiko Saeki
Shuji Saito
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48040245&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO7160021(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of CO7160021A2 publication Critical patent/CO7160021A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

La presente invención se refiere a un virus del herpes aviar recombinante, que comprende al menos dos secuencias de nucleótidos recombinantes, codificando cada secuencia de nucleótidos recombinante un péptido antigénico distinto, en donde dichas al menos dos secuencias de nucleótidos 10 recombinantes se insertan en regiones no codificantes distintas del genoma viral seleccionadas entre la región localizada entre UL44 y UL45, la región localizada entre UL45 y UL46, la región localizada entre US10 y S0RF3, la región localizada entre SORF3 y US2.
CO14215115A 2012-03-30 2014-09-29 Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares CO7160021A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20120305390 EP2644702A1 (en) 2012-03-30 2012-03-30 Multivalent recombinant avian herpes virus and vaccine for immunizing avian species

Publications (1)

Publication Number Publication Date
CO7160021A2 true CO7160021A2 (es) 2015-01-15

Family

ID=48040245

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14215115A CO7160021A2 (es) 2012-03-30 2014-09-29 Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares

Country Status (22)

Country Link
US (6) US10251951B2 (es)
EP (4) EP2644702A1 (es)
JP (2) JP6505593B2 (es)
KR (1) KR102070217B1 (es)
CN (2) CN104364381B (es)
BR (1) BR112014024094A2 (es)
CA (1) CA2868132C (es)
CO (1) CO7160021A2 (es)
ES (2) ES2807952T3 (es)
HU (2) HUE035395T2 (es)
MA (1) MA37446B1 (es)
MX (1) MX357365B (es)
MY (1) MY173016A (es)
PE (2) PE20191704A1 (es)
PH (2) PH12014502162B1 (es)
PL (2) PL2831246T3 (es)
PT (2) PT3219802T (es)
RU (2) RU2658439C2 (es)
TN (1) TN2014000392A1 (es)
UA (1) UA118335C2 (es)
WO (1) WO2013144355A1 (es)
ZA (1) ZA201406979B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2644702A1 (en) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof
CN104120110B (zh) * 2014-07-11 2017-01-18 中国农业科学院哈尔滨兽医研究所 表达增强型绿色荧光蛋白基因的鸭瘟病毒重组疫苗株及其构建方法和应用
CN104212802B (zh) * 2014-09-25 2017-09-12 中国人民解放军第二军医大学东方肝胆外科医院 一种肿瘤细胞广谱高活性启动子及其用途
AR103245A1 (es) 2014-12-24 2017-04-26 Intervet Int Bv Vacuna vectorial basada en hvt (herpes virus de los pavos) frente a nd (enfermedad de newcastle) - ibd (enfermedad de gumboro) mejorada
CN109310750B (zh) 2016-06-17 2022-08-12 英特维特国际股份有限公司 编码传染性喉气管炎病毒和传染性法氏囊病病毒抗原的重组非致病性马立克氏病病毒构建体
CN106350475A (zh) * 2016-08-26 2017-01-25 江苏省农业科学院 一种新型火鸡疱疹病毒的细菌人工染色体、构建方法与应用
EP4112072A1 (en) 2016-12-14 2023-01-04 Boehringer Ingelheim Animal Health USA Inc. Recombinant hvt vectors expressing multiple antigens of avian pathogens, and vaccines comprising them
CN106929483B (zh) * 2017-01-19 2020-09-25 北京邦卓生物科技有限公司 表达鸡新城疫病毒f基因的重组火鸡疱疹病毒的构建及其应用
MX2020003591A (es) * 2017-10-12 2020-07-22 Intervet Int Bv Constructos del virus recombinante no patogenico de la enfermedad de marek que codifica multiples antigenos heterologos.
CN107815469A (zh) * 2017-10-16 2018-03-20 北京市农林科学院 一种重组火鸡疱疹病毒及其制备方法
CN108060141B (zh) * 2017-12-14 2021-05-28 天津瑞普生物技术股份有限公司 Vp2基因和np基因重组腺病毒及其应用
CN109402071B (zh) * 2018-11-08 2021-04-27 中国农业大学 一种表达h9n2亚型禽流感病毒h9蛋白的重组火鸡疱疹病毒
CN113226363A (zh) * 2018-12-21 2021-08-06 法国诗华大药厂 含有多个外来基因的重组禽疱疹病毒
WO2020136220A1 (en) 2018-12-27 2020-07-02 Ceva Sante Animale Recombinant viruses and the uses thereof
MX2022002994A (es) 2019-09-11 2022-06-14 Zoetis Services Llc Vectores de herpesvirus de los pavos recombinante que expresan antígenos de patógenos aviares y usos de estos.
CN110684744A (zh) * 2019-10-22 2020-01-14 青岛易邦生物工程有限公司 一种表达鸡传染性法氏囊病病毒vp2基因的重组火鸡疱疹病毒株
US20230031097A1 (en) 2019-12-20 2023-02-02 Intervet Inc. Multivalent hvt vector vaccine
EP4168043A1 (en) 2020-06-17 2023-04-26 Boehringer Ingelheim Vetmedica GmbH Recombinant hvt vectors expressing influenza hemagglutinin and immunogenic compositions, and production and uses thereof
EP4228683A2 (en) * 2020-10-15 2023-08-23 Ceva Santé Animale Recombinant hvt and uses thereof
WO2022136623A1 (en) 2020-12-24 2022-06-30 Intervet International B.V. Multivalent hvt vector vaccine
WO2023213946A1 (en) 2022-05-05 2023-11-09 Intervet International B.V. New multivalent hvt vector vaccine

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965138A (en) 1985-09-06 1999-10-12 Syntro Corporation Recombinant chimeric virus and uses thereof
EP0256092B1 (en) 1986-01-27 1998-04-08 Syntro Corporation Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
EP0431668B1 (en) 1989-12-04 1995-02-15 Akzo Nobel N.V. Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
JPH06292583A (ja) 1992-03-17 1994-10-21 Nippon Zeon Co Ltd マレック病ウイルス由来の抗原タンパク質、その遺伝子組み換え体、及びそれを用いたワクチン
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
RU2120126C1 (ru) * 1994-08-08 1998-10-10 Всероссийский научно-исследовательский ветеринарный институт птицеводства Способ определения лимфоцитов, сенсибилизированных к вакцине против болезни марека
FR2728795B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire
FR2728794B1 (fr) * 1994-12-30 1997-03-21 Rhone Merieux Vaccin recombinant aviaire a base de virus herpes aviaire, notamment contre la maladie de gumboro
JPH103635A (ja) * 1996-06-12 1998-01-06 Hitachi Ltd 磁気ヘッドスライダ及びこのスライダを用いた磁気ディスク装置
JPH1028586A (ja) * 1996-07-18 1998-02-03 Nippon Zeon Co Ltd アビポックスウイルスの非必須領域、それを用いた組み換えアビポックスウイルス及びワクチン
WO1999018215A1 (fr) * 1997-10-03 1999-04-15 Nippon Zeon Co., Ltd. Recombinants de virus herpetique infectieux aviaire et vaccins recombinants prepares avec ces derniers
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
US6866852B2 (en) * 2002-01-31 2005-03-15 Zeon Corporation Recombinant herpesvirus of turkeys and use thereof
US7029681B2 (en) * 2002-03-08 2006-04-18 Schweitzer Chemical Corporation Multiple and multivalent DNA vaccines in ovo
US7538201B2 (en) 2004-03-29 2009-05-26 Zeon Corporation Recombinant herpesvirus and uses thereof
JP2008228658A (ja) 2007-03-20 2008-10-02 Nippon Zeon Co Ltd 新規なプロモーター、これを有する組み換え七面鳥ヘルペスウイルス、及びこれを利用した家禽用ワクチン
US20080241188A1 (en) * 2007-03-30 2008-10-02 Zeon Corporation Turkey herpesvirus vectored recombinant containing avian influenza genes
JP2009195136A (ja) 2008-02-20 2009-09-03 Nippon Zeon Co Ltd 新規な組換え七面鳥ヘルペスウイルス、及びそれを利用した家禽用ワクチン
CN103893758A (zh) * 2008-09-05 2014-07-02 诗华动物保健股份有限公司 用于给禽类经眼施用疫苗的包含壳聚糖的组合物
PL2419132T3 (pl) * 2009-04-15 2015-03-31 Ceva Sante Animale Wektory z rekombinowanego herpeswirusa ptaków i szczepionki do immunizacji wodnych gatunków ptactwa
PL2768964T3 (pl) 2011-10-21 2019-02-28 Intervet International B.V. Konstrukty rekombinacyjne niepatogennego wirusa choroby mareka kodujące antygeny wirusa zakaźnego zapalenia krtani i tchawicy i wirusa rzekomego pomoru drobiu (choroby newcastle)
PL2785374T5 (pl) 2011-11-30 2023-01-09 Boehringer Ingelheim Animal Health USA Inc. Rekombinowane wektory Gallid herpesvirus3 (MDV serotypu 2) wyrażające antygeny patogenów ptasich i ich zastosowanie
EP2644702A1 (en) 2012-03-30 2013-10-02 Ceva Sante Animale Multivalent recombinant avian herpes virus and vaccine for immunizing avian species
EP2845904A1 (en) 2013-09-06 2015-03-11 Ceva Sante Animale Recombinant Marek's disease viruses and uses thereof

Also Published As

Publication number Publication date
RU2658439C2 (ru) 2018-06-21
PT2831246T (pt) 2017-08-09
JP2019080571A (ja) 2019-05-30
EP2644702A1 (en) 2013-10-02
JP6845266B2 (ja) 2021-03-17
US11123425B2 (en) 2021-09-21
CN104364381A (zh) 2015-02-18
EP3708670A1 (en) 2020-09-16
PH12019501067A1 (en) 2020-07-06
US10245315B2 (en) 2019-04-02
US10500270B2 (en) 2019-12-10
MA20150281A2 (fr) 2015-08-31
EP2831246B1 (en) 2017-05-03
KR102070217B1 (ko) 2020-01-28
MX357365B (es) 2018-07-05
CN104364381B (zh) 2020-07-28
RU2014143830A (ru) 2016-05-27
CA2868132C (en) 2021-08-31
PH12014502162A1 (en) 2014-12-10
PE20191704A1 (es) 2019-11-27
US20210401973A1 (en) 2021-12-30
KR20150003244A (ko) 2015-01-08
RU2018116857A (ru) 2018-10-24
US20180256706A1 (en) 2018-09-13
EP3219802B1 (en) 2020-04-29
ES2807952T3 (es) 2021-02-24
RU2766003C2 (ru) 2022-02-07
PL3219802T3 (pl) 2020-08-24
BR112014024094A2 (pt) 2017-07-18
US20150118250A1 (en) 2015-04-30
PT3219802T (pt) 2020-07-27
US11730807B2 (en) 2023-08-22
US20200108137A1 (en) 2020-04-09
PE20150334A1 (es) 2015-03-25
MX2014011754A (es) 2014-11-26
JP2015512633A (ja) 2015-04-30
RU2018116857A3 (es) 2021-06-08
US10251951B2 (en) 2019-04-09
PH12014502162B1 (en) 2014-12-10
MY173016A (en) 2019-12-19
HUE035395T2 (en) 2018-05-02
ZA201406979B (en) 2016-01-27
JP6505593B2 (ja) 2019-04-24
US20180256707A1 (en) 2018-09-13
UA118335C2 (uk) 2019-01-10
MA37446B1 (fr) 2016-10-31
US20240082390A1 (en) 2024-03-14
CA2868132A1 (en) 2013-10-03
ES2636464T3 (es) 2017-10-05
WO2013144355A1 (en) 2013-10-03
PL2831246T3 (pl) 2017-10-31
EP3219802A1 (en) 2017-09-20
EP2831246A1 (en) 2015-02-04
CN111733143A (zh) 2020-10-02
HUE050602T2 (hu) 2020-12-28
TN2014000392A1 (en) 2015-12-21

Similar Documents

Publication Publication Date Title
CO7160021A2 (es) Virus del herpes aviar recombinantes multivalentes y vacunas para inmunizar especies aviares
CY1124618T1 (el) Ανασυνδυασμενοι hvt φορεις οι οποιοι εκφραζουν αντιγονα παθογονων των πτηνων και χρησεις αυτων
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
PH12018500855A1 (en) Herpes simplex virus vaccine
EP4104854A3 (en) Multivalent vaccines for rabies virus and coronaviruses
WO2015134368A3 (en) Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors
WO2015052543A3 (en) Malaria vaccination
MX2022003590A (es) Vacuna en vector recombinante de adenovirus aviar serotipo 9.
CL2013002631A1 (es) Virus de la necrosis pancreatica infecciosa (ipnv) avirulento porque comprende proteina vp2 madura.
DK3471766T3 (da) Rekombinante, ikke-patogene mareks sygdomsviruskonstrukter, der koder for infektiøs laryngotracheitisvirus- og infektiøs bursitis virus-antigener patentkrav
NZ750578A (en) Viral vaccines
ECSP14023407A (es) Virus de la enfermedad de marek modificado y vacunas elaboradas con él